Şunu aradınız:: gonadotrofini (Maltaca - İngilizce)

katergorija farmakoterapewtika: gonadotrofini.
pharmacotherapeutic group: gonadotrophins.

kategorija farmakoterapewtika: gonadotrofini, kodiċi atc:
97 pharmacotherapeutic group: gonadotrophins, atc code:

wara kura b’ sustanzi tal- gonadotrofini, hemm riskju ogħla ta ’ tqala multipla.
after treatment with gonadotrophin preparations, there is an increased risk of having multiple pregnancies.

wara l- kura b’ sustanzi tal- gonadotrofini, hemm riskju ogħla ta ’ tqala multipla.
after treatment with gonadotrophin preparations, there is an increased risk of having multiple pregnancies.

kategorija farmakoterapewtika: ormoni tas-sess u modulatori tas-sistema ġenitali, gonadotrofini; kodiċi atc: g03g a06.
pharmacotherapeutic group: sex hormones and modulators of the genital system, gonadotrophins; atc code: g03g a06.

ir-rispons tal-ovarji għall-gonadotrofini eżoġeniċi ivarja ħafna kemm fl-istess individwu, kif ukoll bejn individwi differenti.
there are great inter- and intra-individual variations in the response of the ovaries to exogenous gonadotrophins.

f’ każijiet rari, it- tromboemboliżmu ġie assoċjat ma ’ terapija b ’ puregon/ hcg kif ukoll ma ’ gonadotrofini oħra.
in rare instances, thromboembolism has been associated with puregon/ hcg therapy as with other gonadotrophins.

18 għadu mhux stabbilit jekk il- kura bil- gonadotrofini żżidx ir- riskju mir- referenza bażi ta ’ dawn it- tumuri f’ nisa infertili.
it is not yet established whether or not treatment with gonadotrophins increases the baseline risk of these tumours in infertile women.